星湖科技(600866.SH):控股子公司擬開展玉米期貨套期保值業務
格隆匯5月31日丨星湖科技(600866.SH)公佈,為充分利用期貨市場功能,有效控制原料價格風險,鎖定經營成本和利潤,增強抗風險能力,合理規避原料價格波動給經營帶來的不利影響,提升企業經營水平,保障企業健康持續運行,子公司伊品生物擬利用相關期貨及期權市場的套期保值功能,開展玉米套期保值業務,提升公司整體抵禦風險能力,增強財務穩健性。伊品生物開展期貨套期保值業務佔用的期貨賬户資金上限為5,000萬元(含持倉保證金和應付行情變化風險金),佔用的期貨合約貨值上限為50,000萬元。期貨交易不提供擔保物,不使用銀行授信,不進行實物交割。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.